- Home
- EIG vs XNCR Comparison
EIG vs XNCR Comparison
Compare EIG & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIG
- XNCR
- Stock Information
- Founded
- EIG 2000
- XNCR 1997
- Country
- EIG United States
- XNCR United States
- Employees
- EIG N/A
- XNCR N/A
- Industry
- EIG Property-Casualty Insurers
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- EIG Finance
- XNCR Health Care
- Exchange
- EIG Nasdaq
- XNCR Nasdaq
- Market Cap
- EIG 1.2B
- XNCR 1.3B
- IPO Year
- EIG 2007
- XNCR 2013
- Fundamental
- Price
- EIG $49.34
- XNCR $17.76
- Analyst Decision
- EIG Strong Buy
- XNCR Strong Buy
- Analyst Count
- EIG 1
- XNCR 8
- Target Price
- EIG $58.00
- XNCR $34.63
- AVG Volume (30 Days)
- EIG 120.5K
- XNCR 534.5K
- Earning Date
- EIG 02-20-2025
- XNCR 02-25-2025
- Dividend Yield
- EIG 2.43%
- XNCR N/A
- EPS Growth
- EIG 20.58
- XNCR N/A
- EPS
- EIG 5.34
- XNCR N/A
- Revenue
- EIG $889,800,000.00
- XNCR $85,164,000.00
- Revenue This Year
- EIG N/A
- XNCR N/A
- Revenue Next Year
- EIG $1.18
- XNCR $80.86
- P/E Ratio
- EIG $9.25
- XNCR N/A
- Revenue Growth
- EIG 5.05
- XNCR N/A
- 52 Week Low
- EIG $38.67
- XNCR $15.31
- 52 Week High
- EIG $54.44
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- EIG 44.03
- XNCR 28.92
- Support Level
- EIG $49.24
- XNCR $19.15
- Resistance Level
- EIG $50.10
- XNCR $19.45
- Average True Range (ATR)
- EIG 0.87
- XNCR 0.97
- MACD
- EIG 0.08
- XNCR -0.15
- Stochastic Oscillator
- EIG 40.63
- XNCR 11.60
About EIG Employers Holdings Inc
Employers Holdings Inc provides workers' compensation insurance, to small businesses in low- to medium-hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through itswholly owned subsidiaries.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.